ScaleReady offers a platform for truly scalable and practical cell and gene therapy manufacturing. By automating cell processing around rapid cell production in G-Rex® closed-system bioreactors, our platform maximizes manufacturing capacity and product consistency while maintaining flexibility to support any process. Our goal is to make cell therapy manufacturing commercially sustainable by enabling scale up and scale out with practicality, speed, and consistency. ScaleReady is a joint venture between Bio-Techne, Fresenius Kabi, and Wilson Wolf.